EU approval for Sanofi Pasteur's intradermal flu vaccine
This article was originally published in Scrip
Executive Summary
The first intradermal microinjected seasonal influenza vaccine, Sanofi Pasteur's Intanza/IDflu, has been approved by the European Commission for the prevention of flu in both adult and elderly populations and will be available for the 2009-10 season.